您当前的位置：
首页 >
文章列表页 >
Clinical observation of Shouhui tongbian capsule combined with linaclotide in the treatment of constipation-predominant irritable bowel syndrome
更新时间：2025-11-25

    • Clinical observation of Shouhui tongbian capsule combined with linaclotide in the treatment of constipation-predominant irritable bowel syndrome

    • “In the field of treating constipation predominant irritable bowel syndrome, experts from the First People's Hospital of Nanyang City have verified the efficacy and safety of Shouhui Tongbian Capsules combined with Linalotide, providing a solution to improve patients' quality of life.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 22, Pages: 2828-2832(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.22.13    

      CLC： R969.4;R574.6

    • Received：08 July 2025，

      Revised：2025-10-10，

      Accepted：13 October 2025，

      Published：30 November 2025

    移动端阅览

  • HAO Manxia,WANG Shengwen,YAO Lishan.Clinical observation of Shouhui tongbian capsule combined with linaclotide in the treatment of constipation-predominant irritable bowel syndrome[J].ZHONGGUO YAOFANG,2025,36(22):2828-2832. DOI： 10.6039/j.issn.1001-0408.2025.22.13.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Efficacy and safety comparison of dupilumab versus thalidomide in the treatment of refractory prurigo nodularis in adults
Advances in the clinical application and safety of bispecific antibodies for cancer therapy
Efficacy and safety of ruxolitinib in the treatment of myelofibrosis
Clinical observation of doxycycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children under 8 years of age
Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors combined with bevacizumab in the treatment of advanced non-small cell lung cancer

Related Author

ZHANG Jianbo
HU Lei
HUANG Hegui
LIU Yangcong
WANG Xiaoxian
LIN Mengmeng
LIN Xu
WANG Yixuan

Related Institution

Dept. of Pharmacy， Wuhan First Hospital
Dept. of Clinical Pharmacy， Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province， Affiliated Hangzhou First People’s Hospital， School of Medicine， Westlake University
Dept. of Thoracic Surgery， the First Affiliated Hospital， Zhejiang University School of Medicine
School of Pharmaceutical Sciences， Zhejiang Chinese Medical University
School of Pharmaceutical Sciences， Wenzhou Medical University
0